PeripheralPulmonary Eosinophilia with pulmonary symptoms - PowerPoint PPT Presentation

1 / 28
About This Presentation
Title:

PeripheralPulmonary Eosinophilia with pulmonary symptoms

Description:

HEENT: PERRL, no sinus drainage or nasal polyps, no mucosal ulcers ... Radiation to the Chest. Miscellaneous lung disease with lesser degree of eosinophilia 25 ... – PowerPoint PPT presentation

Number of Views:163
Avg rating:3.0/5.0
Slides: 29
Provided by: johnm104
Category:

less

Transcript and Presenter's Notes

Title: PeripheralPulmonary Eosinophilia with pulmonary symptoms


1
(No Transcript)
2
AM Report
  • Feb 15, 2006

3
HPI
  • 38 yo white male previously healthy
  • 6 months prior to admission gradual onset of dry
    cough, low grade fever, DOE, wheezing.
  • Multiple visits to PCP, treated as asthma with
    inhalers, abx and steroid taper with rapid
    improvement, but relapse 1-2 weeks after
    finishing treatment.

4
HPI
  • Exposure to a flooded rental apartment, and
    pulled up a wet, stinky carpet. Immediately
    after he experienced bout of coughing and SOB.

5
PMHx
  • Glaucoma
  • Mild seasonal allergies

6
Meds
  • Xalatan 0.005 eye drops
  • Tylenol prn
  • Albuterol MDI prn
  • Advair 1 puff bid
  • Completed course of Ketek/prednisone taper 2
    weeks ago

7
ROS
  • fatigue, intermittent low grade fevers, night
    sweats
  • SOB, DOE, wheezing, dry cough
  • No rhinitis/sinusitis
  • No CP, orthopnea, PND
  • No rash, skin lesions
  • No myalgias/arthralgias
  • No LAD
  • No GI/GU/neuro complaints

8
FHx SHx
  • Father in his 60s with DM2, recent MI
  • Mother HTN
  • 2 Brothers healthy
  • Linconton, NC with wife and 2 children
  • Mechanic
  • Non-smoker
  • 5 years ago Salmon Fishing in Alaska
  • Pulled up a wet carpet prior to initial
    presentation

9
PE
  • VS 37.9, 96, 24, 130/76, 87 RA
  • Mild increased work of breathing.
  • HEENT PERRL, no sinus drainage or nasal polyps,
    no mucosal ulcers
  • CV RRR, S1, S2, PMI nondisplaced, no m/r/g. No
    JVD. Pulses 2.
  • Lungs scattered crackles and wheezing
  • Abdomen unremarkable
  • Skin No rash

10
Labs
  • WBC 22.6 21 eosinophils, AEC 4.75
  • Eosinophils decreased to 0 on steroids
  • Chem 10, LFTs wnl
  • CXR- diffuse/patchy alveolar opacity
  • Chest CT- peripheral, upper lobe predominant,
    patchy pneumonitis

11
Labs
  • IgE 2473
  • Expectorated sputum 40 eosinophils
  • Stool O/P negative x4
  • Sputum O/P, AFB, fungal, Cx negative
  • Aspergillus Ab lt 18
  • Strongyloides Ab negative
  • Toxocara Canis Ab negative
  • ANCA lt 116

12
Labs
  • PFTs FEV1 76 pred
  • TTE EF gt 55, nl valves
  • CXR cleared with treatment
  • Bone Marrow Bx normocellular with normal marrow
    elements, no cytogenetic abnormalities
  • Flow cytometry no evidence of monoclonality

13
Idiopathic Chronic Eosinophilic Pneumonia
14
DDx Blood Eosinophilia
15
DDx of Pulmonary Eosinophilia
  • Idiopathic
  • Pulmonary
  • Idiopathic chronic eosinophilic pneumonia (ICEP)
  • Idiopathic acute eosinophilic pneumonia (IAEP)
  • Pulmonary extrapulmonary
  • Churg Strauss Syndrome (CSS)
  • Hypereosinophilic syndromes (HES)
  • Parasitic infections
  • Wuchereria bancrofti, Ascaris, Toxocara Canis,
    Strongyloides
  • ABPA and other fungi/yeast
  • Drugs/Toxins
  • Aspirin, Captopril, Naproxen, Penicillin,
    Ethambutol, GM-CSF, Ibuprofen, Bactrim,
    L-tryptophan, crack/heroin, dust
  • Radiation to the Chest
  • Miscellaneous lung disease with lesser degree of
    eosinophilia lt25
  • Sarcoidosis
  • Asthma and eosinophilic bronchitis
  • Lung Transplantation
  • Langerhans Cell Granulomatosis
  • Paraneoplastic Eosinophilic Pneumonia
  • Acute eosinophilic leukemia, lymphoma

16
Eosinophilic Pneumonia
  • Pulmonary symptoms
  • Infiltrate on CXR/CT
  • Pulmonary eosinophilia BAL gt25

17
Acute Eosinophilic Pneumonia
  • Acute onset of EP
  • Often quite severe meeting criteria for ALI or
    ARDS and requiring intubation.
  • Rapid response to steroids
  • No relapse after recovery
  • Often associated with exposure 9/11 firefighter,
    tear gas, tobacco smoke

18
Churg Strauss Syndrome
  • Small vessel vasculitis associated with
    asthma/rhinitis and eosinophilia
  • Dx asthma eosinophilia 2 or more
    extrapulmonary organs(skin,GI, cardiac, neuro),
    frequently ANCA
  • Tx Corticosteroids
  • Cytotoxic agents for poor prognostic factors.

19
Hypereosinophilic Syndrome-HES
  • Lymphocytic Variant
  • Clonal TH2 lyphocytes overproducing IL-5
  • Cutaneous papules or urticarial plaques
    infiltrated with eosinophils/lymphocytes
  • Tx corticosteroids
  • anti- IL5
  • Myeloproliferative Variant
  • 4q12 deletion causing Fip1L1-PDGFRa fusion
    protein
  • Cardiac involvement
  • endomyocardial fibrosis/mural thrombus
  • HSM, anemia, thrombocytopenia, mucosal ulcers
  • Acute eosinophilic Leukemia
  • Tx corticosteroids
  • Gleevec

20
Idiopathic Chronic Eosinophilic Pneumonia
  • gradual and progressive onset of EP without
    documented etiology.
  • Lack of extrapulmonary disease.

21
Epidemiology
  • Non-smoker
  • 21 female to male
  • Asthma in 50 prior to Dx
  • Mean age at Dx 45

22
Clinical Presentation
  • Pulmonary/systemic symptoms- non-productive
    cough, dyspnea, wheezing, fatigue, malaise, fever
  • Gradual/progressive onset over weeks
  • Lack of extrapulmonary symptoms
  • Lung exam wheezes/crackles

23
Diagnosis
  • BAL eosinophilia gt 25 but usually gt40, mean 58
  • Peripheral blood eosinophilia AEC gt 1000
  • Typically gt 6 of WBC, mean 32
  • ESR, CRP, IgE often elevated
  • Infiltrate on CXR/CT
  • Lung biopsy rarely indicated

24
Imaging
  • CXR- peripheral predominance of alveolar
    infiltrates classically described as the
    photographic negative of pulmonary edema
  • CT- bilateral, diffuse, patchy, upper lobe
    predominant with coexisting ground glass and
    consolidation
  • May see small pleural effusion, mediastinal LAD
  • Opacities resolve rapidly with corticosteroids

25
Treatment
  • Uniformly responsive to Corticosteroids
  • Prednisone 1 mg/kg tapered 2 week after
    symptom resolution, then 0.5 mg/kg x 8 weeks,
    then decrease 5 mg q 4 weeks.
  • Symptoms improve within 48 hours to 1 week
  • CXR opacities clear within 1 week
  • Relapse is common 50-80
  • Frequently require years of steroids (mean 1.9
    years)
  • Inhaled steroids may decrease relapse rate
  • 2nd Line cytotoxic agents, anti-IL5

26
Natural history
  • May resolve spontaneously 10
  • The majority resolve after 6 months to years of
    corticosteroids.
  • Relapse not indicative of worse prognosis or
    increased morbidity.
  • Some require lifelong corticosteroids.
  • Occasionally the intial manifestation of CSS,
    prior to the vasculitic phase.
  • Rarely can result in physiologically detectable
    fibrosis.

27
References
  • Cottin, V. Cordier, J.-F. (2005) Eosinophilic
    pneumonias. Allergy 60 (7), 841-857.
  • Jederlinic, PJ, Sicilian, L, Gaensler, EA.
    Chronic eosinophilic pneumonia. A report of 19
    cases and a review of the literature. Medicine
    1988 67154.
  • Naughton, M, Fahy, J, FitzGerald, MX. Chronic
    eosinophilic pneumonia. A longterm followup of 12
    patients. Chest 1993 103162.

28
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com